Fady Boctor - 02 Jan 2026 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role: President & Chief Commercial Officer
Signature: /s/ Fady Boctor
Issuer symbol: PTPI
Transactions as of: 02 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2026, 17:30:07 UTC
Previous filing: 21 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Boctor Fady	President & Chief Commercial Officer	1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK	/s/ Fady Boctor	06 Jan 2026	0001833394

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTPI	Common Stock	Award	$0	+500,000	+2502%	$0.000000	519,986	02 Jan 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the "Common Stock"), of the Issuer.
F2	Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025.

Remarks:

President & Chief Commercial Officer